Press release
Moderna and Coursera Launch Free Course on mRNA Technology
Companies share joint commitment to leveraging technology for STEM educationAccessible education on cutting-edge science and technology represents critical
About this update from Moderna, Inc.
[{"type":"text","content":"Companies share joint commitment to leveraging technology for STEM educationAccessible education on cutting-edge science and technology represents critical step toward closing workforce readiness gap CAMBRIDGE, MA and MOUNTAIN VIEW, CA / ACCESSWIRE / August 14, 2024 / Moderna, Inc. (NASDAQ:MRNA) and Coursera (NYSE:COUR) today announced a partnership to launch mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential applications. mRNAs as Medicines is available for free to individuals who register as Coursera learners.\"At Moderna, we obsess over learning and believe when education is accessible, it can transform our lives and communities,\" said Tracey Franklin, Chief Human Resources Officer of Moderna. \"By partnering with Coursera to offer this free course to everyone, we can help people deepen their understanding of mRNA science, how it represents a new era of medicine, and its power to positively impact human health.\"\"We're excited to welcome Moderna to the Coursera platform as the demand for STEM skills continues to grow around the world,\" said Marni Baker-Stein, Chief Content Officer at Coursera. \"By offering the ‘mRNAs as Medicines' course for free, we are empowering learners worldwide to gain an in-depth understanding of the revolutionary and life-saving mRNA technology directly from Moderna experts. This initiative not only supports current and aspiring medical professionals, it makes it easier and more affordable for anyone to start their learning journey in this critical field.\"mRNA can teach the body how to make its own medicines in the form of proteins. Through mRNAs as Medicines, learners will explore the structure of proteins and mRNAs, how they are made, and their roles in the body. The course also examines the properties of classic, small molecule medicines and how technological advances can enable the use of proteins and mRNAs as therapeutic agents. Additionally, it explores how mRNA medicines have the potential to prevent and treat diseases, including their applications as vaccines, therapies and treatments for genetic disorders and regenerative medicine. The course will be available to learners globally.An estimated 3.5 million STEM jobs will need to be filled in the U.S. by 2025, and Moderna an...